404 results on '"Satoh T"'
Search Results
2. Correlated oscillations in Kerr parametric oscillators with tunable effective coupling
3. Association of PD-L1 and PD-L2 expression and tumor-infiltrating lymphocytes in BRAF V600E-mutated metastatic colorectal cancer: GI-SCREEN post-hoc analysis
4. Stability of quay wall backfilled by lightweight geo-material during earthquake
5. A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
6. Age-related variation of homing range in honeybee males (Apis mellifera)
7. OA05.05 Ifinatamab Deruxtecan (I-DXd; DS-7300) in Patients with Refractory SCLC: A Subgroup Analysis of a Phase 1/2 Study
8. Effects of titanium fluoride on caries inhibition and elemental distribution in the tooth structure: Comparisons with sodium fluoride at the same fluoride concentration and pH values
9. Correlated Oscillations in Kerr Parametric Oscillators with Tunable Effective Coupling
10. Study on chemical forms of aluminum in tea leaves using micro-PIXE method.
11. AB0083 CD14+CD90+ CELLS IN PERIVASCULAR AREAS OF RHEUMATOID ARTHRITIS SYNOVIAL TISSUES HAVE POTENTIAL TO DIFFERENTIATE INTO DENDRITIC CELLS
12. 650 Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: Pooled results from two phase 3 trials (liberty-pn prime and prime2)
13. 117 Indiscernible skin transcriptome in Stevens-Johnson syndrome and toxic epidermal necrolysis induced by immune checkpoint inhibitors and other culprit drugs
14. 009 The transcriptome of Sweet syndrome suggests a pathogenic role of both innate and adaptive immune signaling pathways
15. 018 Evidence for IL-31/IL-31RA axis involvement in psoriasis and autoimmune skin diseases beyond atopic dermatitis and prurigo nodularis
16. 881 Establishment of in vitro model of IL-36Ra dysfunction in a human keratinocyte cell line by IL36RN knockout using CRISPR/Cas9 system
17. 906 A novel IL-31-generating mechanism in atopic dermatitis: essential roles of macrophages in cooperation with basophils, thymic stromal lymphopoietin and periostin
18. Lys48-linked K48C-diubiquitin
19. APPLICATION OF PRE-TRAINED REAL-WORLD SUPER RESOLUTION MODELS TO OPTICAL SATELLITE IMAGE
20. 32O 5-year (y) overall survival (OS) with maintenance olaparib (ola) plus bevacizumab (bev) by clinical risk in patients (pts) with newly diagnosed advanced ovarian cancer (AOC) in the phase III PAOLA-1/ENGOT-ov25 trial
21. Observation of Third-Harmonic Oscillation from Nonlinear Spin Precession Induced by Terahertz Magnetic Fields
22. 46MO FRESCO-2: A global / multiregional phase III clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with metastatic colorectal cancer
23. LBA25 FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer
24. LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinoma
25. 440TiP TRESBIEN (OGSG 2101): Encorafenib, binimetinib and cetuximab for early relapse stage II/III BRAF V600E-mutated CRC
26. 1515P Surgery versus chemotherapy for pulmonary oligometastasis after pancreatectomy: A multicentre observational study
27. 714MO Datopotamab deruxtecan (Dato-DXd) in patients with endometrial (EC) or ovarian cancer (OC): Results from the phase II TROPION-PanTumor03 study
28. 526P Efficacy and safety of fruquintinib in refractory metastatic colorectal cancer: A FRESCO-2 subgroup analysis by age
29. Dupilumab improves both histaminergic and touch‐evoked itch sensitization (hyperknesis) in atopic dermatitis: a pilot study
30. P-78 A phase II study of resection followed by capecitabine plus oxaliplatin for liver metastasis of colorectal cancer (REX study): Final analysis
31. Correlation of Venusian Mesoscale Cloud Morphology Between Images Acquired at Various Wavelengths
32. P-15 Histology classification highlights the difference in the effectiveness of S-1 over capecitabine when combined with cisplatin in patients with HER2-negative unresectable advanced or recurrent gastric cancer with measurable disease
33. Therapeutic potential of targeting interleukin-1 family cytokines in chronic inflammatory skin diseases
34. Spectroscopic observation of the crossover from a classical Duffing oscillator to a Kerr parametric oscillator
35. Comparison of low-dose-rate brachytherapy versus radical prostatectomy in patients with intermediate-risk prostate cancer: A propensity-matched multi-institutional study
36. Age-related variation of homing range in honeybee males (Apis mellifera)
37. LBA76 The primary results of an intergroup phase III randomized controlled trial comparing ramucirumab plus irinotecan with irinotecan in the third or later line treatment beyond progression after ramucirumab for advanced gastric cancer (RINDBeRG trial)
38. 690P Ifinatamab deruxtecan (I-DXd; DS-7300) in patients with advanced solid tumors: Updated clinical and biomarker results from a phase I/II study
39. 654O Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with solid tumors harboring specific HER2-activating mutations (HER2m): Primary results from the international phase II DESTINY-PanTumor01 (DPT-01) study
40. 102P Potentially prognostic factors of overall survival in advanced biliary tract cancer in the randomised phase III TOPAZ-1 study
41. SO-10 Phase 2 study of futibatinib in patients with specific FGFR aberrations: Activity in patients with gastric or gastroesophageal junction cancer harboring FGFR2 amplification
42. SO-1 A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH1 and IDH2, as monotherapy and in combination with cisplatin and gemcitabine in advanced IDH-mutant cholangiocarcinoma
43. P-23 Clinical outcomes of encorafenib, binimetinib, and cetuximab for pretreated BRAF V600E-mutant metastatic colorectal cancer in the BEACON EAP follow-up study
44. A0957 - Comparison of low-dose-rate brachytherapy versus radical prostatectomy in patients with intermediate-risk prostate cancer: A propensity-matched multi-institutional study
45. CD14+CD90+ CELLS IN PERIVASCULAR AREAS OF RHEUMATOID ARTHRITIS SYNOVIAL TISSUES HAVE POTENTIAL TO DIFFERENTIATE INTO DENDRITIC CELLS.
46. 881 Establishment of in vitromodel of IL-36Ra dysfunction in a human keratinocyte cell line by IL36RN knockout using CRISPR/Cas9 system
47. PS3-3 Clinical and biomarker data from a phase 1/2 trial of ifinatamab deruxtecan (I-DXd; DS-7300) in advanced solid tumors.
48. MO50-6 Characterization of patients with advanced biliary tract cancer by KRAS alteration subtypes.
49. 93P Efficacy and safety of fruquintinib (F) + best supportive care (BSC) vs placebo (P) + BSC in refractory metastatic colorectal cancer (mCRC): Asian vs non-Asian outcomes in FRESCO-2.
50. Captopril prevents depressive-like behavior in an animal model of depression by enhancing hippocampal neurogenesis via activation of the ACE2/Ang (1-7)/Mas receptor/AMPK/BDNF pathway.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.